Searched for
AYURVEDIC PRODUCTS MANUFACTURER
Payoneer India Cross-Border Excellence Awards 2026: From fashion to wellness, spotlighting India's e-commerce export championsThe Payoneer India Cross-Border Excellence Awards 2026 celebrate India's rising exporters, spotlighting e-commerce leaders in fashion, home...- US drug regulator issues import alert for drugs made at a Dabur India plantThe US Food and Drug Administration has placed Dabur India's factory on an import alert. This action follows an inspection that revealed si...
- No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling caseThe Maharashtra government has assured the Bombay High Court it will halt raids and confiscations concerning ayurvedic product labels. This...
- U.S. drug regulator flags data integrity, maintenance lapses at Dabur India plantThe U.S. FDA has identified significant data integrity and manufacturing lapses at a Dabur India plant following a January inspection. Find...
- Karnataka HC stays FSSAI advisory on use of Ashwagandha in major relief to US-based Kerry Inc, 7 other firmsIn a significant decision, the Karnataka High Court has granted temporary relief to eight businesses, including Kerry Inc, putting a hold o...
- I-Beauty! After J, K and C, now it's India's turn in the big beautiful marketIndia's beauty industry is emerging as a global force, blending Ayurvedic heritage with modern science to create "I-beauty." With rising ex...
- Different packaging, typos expose fake Mounjaro racketGurugram authorities uncovered a counterfeit Mounjaro operation. Police seized fake diabetes and weight loss injections valued at ₹70 lakh....
- FSSAI launches dedicated licensing window for Ayurveda Aahara productsFood Safety and Standards Authority of India has started a licensing window for Ayurveda Aahara. Manufacturers can now apply for licenses o...
- Dabur announces fresh investment of Rs 550 croreThe company said in a statement the new plant, which would be involved in the production of making foods, ayurvedic medicines and health su...
- AYUSH Ministry's manufacturing unit IMPCL achieves highest-ever turnover of over Rs 160 croreThis growth is reflective of the fast-growing adoption of AYUSH products and services by the public following the outbreak of the COVID-19 ...
- Emami to expand ayurvedic product export under ZanduEmami plans to export its healthcare portfolio under Zandu into several newer markets with the company receiving the WHO-GMP and Certificat...
- Amazon to open a store for Indian ayurvedic manufacturersAmazon India, said herbal and beauty is the biggest category on Amazon.com. It offers a big opportunity for ayurvedic product manufacturers...
- High GST rate on ayurvedic items: How can one feel 'Achhe Din', asks PatanjaliGST rate for classical or generic range of ayurvedic medicines must be nil and 5 per cent for patented products instead of the proposed 12 ...
- Central body to check quality of new ayurvedic drugs likelyThe ministry of ayurveda, yoga and naturopathy, unani, siddha and homoeopathy (AYUSH) has sought the opinion of the law ministry on setting...
- AVA Healthcare ties up with Ambika PillaiAVA Healthcare promoter Dr A.V. Anoop said the Kaytra brand would first be launched in Kerala and then extended to other states in the coun...
- Chhattisgarh plans to start large scale production of herbal drugsAs per the plan, Ayurvedic drug manufacturers would be invited to set up herbal drug production units in the state, based on PPP mode.
- CARE assigns ‘AA’ rating to Emami’s NCD issueCARE has assigned AA rating to the Rs.100 crore long-term loan/non-convertible debenture programme of Emami Ltd.
- Ayurvedic Association agreement with American Herbal AssociationAyurvedic Drug Manufacturers Association has entered into an agreement of cooperation with American Herbal Products Association, US.
- Sunbeam Remedies eyes Rs 300 cr turnoverMumbai-based pharma start-up Sunbeam Remedies, a part of the Rs 1000 crore Orind Shashwat group, which has prime interests in the refractor...
- NPIL expects Rs 1,000 cr revenueAs the costs of medicines are high abroad, the MNCs need Indian companies to manufacture their products.
Load More
